Cartalax is an advanced cartilage-targeting bioregulator peptide that promotes chondrocyte renewal and collagen-matrix integrity. Its short amino-acid sequences penetrate articular tissue to restore the gene expression patterns essential for flexible, resilient joints.
Cartalax is a precision-engineered bioregulator peptide that selectively targets cartilage tissue through epigenetic signalling pathways. Developed from decades of Khavinson peptide research, each capsule contains ultra-short amino acid sequences (2-4 residues) that penetrate cell membranes to interact directly with tissue-specific DNA. By restoring natural gene expression patterns within cartilage tissue cells, Cartalax helps normalise chondrocyte regeneration and collagen-matrix synthesis—functions that progressively decline with age, stress, and environmental exposure. The peptide does not introduce foreign substances; instead, it reactivates the body's own molecular programmes for musculoskeletal tissue maintenance, making it a fundamentally different approach from conventional supplementation.
Cartalax – Cartilage & Longevity Peptide belongs to the family of short-peptide bioregulators developed in the Khavinson research lineage. These peptides interact with gene promoter regions inside specific tissue cells, helping restore physiological protein synthesis in the target organ. Most users take it as part of a 1–3 month cyclical protocol.
Standard adult use is 1–2 capsules per day, taken 15–20 minutes before food, for a 30-day cycle. Cycles can be repeated 2–4 times per year depending on individual goals and clinical guidance. Always follow the dosage instructions on the product label and consult a qualified healthcare professional for personalised protocols.
Khavinson-lineage peptide bioregulators have an extensive safety record across 40+ years of published research, with low reported incidence of side effects. However, individual responses vary. Discontinue use and consult a healthcare professional if you experience any adverse reaction, and avoid use during pregnancy, breastfeeding or in combination with prescription medications without medical supervision.
Every batch is manufactured by EU GMP-audited partners and verified by HPLC for peptide identity. PeptideComb provides Certificates of Analysis on request and tests every production batch for microbial safety and heavy-metal residues.
Orders typically ship within 1–2 business days via DHL or FedEx, with worldwide delivery in 3–10 business days. PeptideComb offers a 14-day return policy on unopened products with free return shipping in line with EU consumer rights.